SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Zeev's Turnips - No Politics -- Ignore unavailable to you. Want to Upgrade?

To: seminole who wrote (34652)2/28/2002 10:45:13 AM
From: TimeToMakeTheInvs  Read Replies (1) | Respond to of 99280
 
Richard, I have played with ENMD before whose endostatin drug got orphan status today but it has gotten murdered lately (and Zeev thinks they will need to find additional funding if I understood him correctly). tim
PS Oops, just saw your message re your trade today.



To: seminole who wrote (34652)2/28/2002 11:32:56 AM
From: Jdaasoc  Read Replies (1) | Respond to of 99280
 
Erbitux may be very promising but IMCL is going to need to find some mo money to finish drug trials, finish production plant etc., if the earliest FDA will rule on revised app is 2003. I just don't like risk/reward for shareholder value in the near term.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News